22 research outputs found
Receiver operating characteristic (ROC) curves, areas under the curve (AUROC), and cut-off values in the different scenarios for significant fibrosis (Panel A) and severe fibrosis (Panel B).
<p>Receiver operating characteristic (ROC) curves, areas under the curve (AUROC), and cut-off values in the different scenarios for significant fibrosis (Panel A) and severe fibrosis (Panel B).</p
Distribution of liver stiffness measurements in 1,001 blood donors.
<p>Distribution of liver stiffness measurements in 1,001 blood donors.</p
Estimates benefit/harm ratios for the six scenarios estimated by 10 Italian hepatology centers.
<p>Estimates benefit/harm ratios for the six scenarios estimated by 10 Italian hepatology centers.</p
Harm/benefit ratios and corresponding liver stiffness cut-off values in all the scenarios.
<p>Harm/benefit ratios and corresponding liver stiffness cut-off values in all the scenarios.</p
Demographic and clinical characteristics of HCV patients concomitantly undergoing TE and liver biopsy assessments of liver stiffness.
<p>Demographic and clinical characteristics of HCV patients concomitantly undergoing TE and liver biopsy assessments of liver stiffness.</p
Mean hemoglobin values during treatment with PR+TVR stratified by ITPA deficiency.
<p>Mean hemoglobin values during treatment with PR+TVR stratified by ITPA deficiency.</p
Degrees of ITPA deficiency according to rs1127354/rs7270101 genotypes combinations (0–3: no ITPA deficiency, mild, moderate or severe deficiency).
<p>Degrees of ITPA deficiency according to rs1127354/rs7270101 genotypes combinations (0–3: no ITPA deficiency, mild, moderate or severe deficiency).</p
DAAHCVGNTablesIFNmodified – Supplemental material for Immunosuppressive and antiviral treatment of hepatitis C virus–associated glomerular disease: A long-term follow-up
<p>Supplemental material, DAAHCVGNTablesIFNmodified for Immunosuppressive and antiviral treatment of hepatitis C virus–associated glomerular disease: A long-term follow-up by Fabrizio Fabrizi, Alessio Aghemo, Pietro Lampertico, Mirella Fraquelli, Donata Cresseri, Gabriella Moroni, Patrizia Passerini, Francesca M Donato, Piergiorgio Messa in The International Journal of Artificial Organs</p
Hemoglobin decline at week 4 of therapy and management of anemia stratified by ITPA deficiency.
<p>*No ITPA deficiency vs any ITPA deficiency.</p